Rituximab as First-Line Maintenance Therapy Following Rituximab-Containing Therapy for Follicular LymphomaProfile Report

被引：0
|
作者：
Jamie D. Croxtall
机构：
[1] Adis,
[2] a Wolters Kluwer Business,undefined
来源：
BioDrugs | 2011年 / 25卷
关键词：
Maintenance Therapy; Induction Therapy; Follicular Lymphoma; Observation Group; Progressive Multifocal Leukoencephalopathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：329 / 331
页数：2
相关论文
共 50 条
  • [1] Rituximab As First-Line Maintenance Therapy Following Rituximab-Containing Therapy for Follicular Lymphoma
    Croxtall, Jamie D.
    DRUGS, 2011, 71 (07) : 885 - 895
  • [2] Rituximab as First-Line Maintenance Therapy Following Rituximab-Containing Therapy for Follicular Lymphoma Profile Report
    Croxtall, Jamie D.
    BIODRUGS, 2011, 25 (05) : 329 - 331
  • [3] RituximabAs First-Line Maintenance Therapy Following Rituximab-Containing Therapy for Follicular Lymphoma
    Jamie D. Croxtall
    Drugs, 2011, 71 : 885 - 895
  • [4] Approved Rituximab for First-Line Maintenance Therapy
    不详
    ONKOLOGE, 2010, 16 (12): : 1201 - 1201
  • [5] Rituximab Maintenance Therapy After First-Line induction Chemoimmunotherapy for Follicular Lymphoma
    Hilal, Talal
    Leis, Jose F.
    Reeder, Craig B.
    JAMA ONCOLOGY, 2018, 4 (06) : 859 - 860
  • [6] Bendamustine and rituximab triumphs as first-line therapy
    Nature Reviews Clinical Oncology, 2012, 9 (8) : 428 - 428
  • [7] Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study)
    Schneider, Tamas
    Rosta, Andras
    Losonczy, Hajna
    Radvanyi, Gaspar
    Ujj, Gyorgy
    Egyed, Miklos
    Illes, Arpad
    Jakucs, Janos
    Szerafin, Laszlo
    Gasztonyi, Zoltan
    Masszi, Tamas
    Ivanyi, Janos
    Demeter, Judit
    Dombi, Peter
    Toth, Antal
    Borbenyi, Zita
    PATHOLOGY & ONCOLOGY RESEARCH, 2018, 24 (02) : 199 - 205
  • [8] Rituximab maintenance therapy in follicular lymphoma
    Forstpointner R.
    Dreyling M.
    Current Hematologic Malignancy Reports, 2007, 2 (4) : 213 - 218
  • [9] Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance
    Kim, Hee Kyung
    Kang, Wonseok
    Sinn, Dong Hyun
    Lee, Joon Hyeok
    Kim, Won Seog
    Kim, Seok Jin
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (01): : 194 - +
  • [10] Is rituximab maintenance therapy useful following rituximab salvage in refractory or relapsed follicular lymphoma?
    Ritchie, David
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (07): : 402 - 403
12345